Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease.
- Resource Type
- Article
- Source
- Inflammatory Bowel Diseases; Jun2007, Vol. 13 Issue 6, p693-702, 10p
- Subject
- Language
- ISSN
- 10780998